FASTinov Welcomes Mr. George Skinner as Director of Commercial Operations

FASTinov Welcomes Mr. George Skinner as Director of Commercial Operations

October 24th 2023

(Porto, Portugal) – FASTinov is delighted to announce the appointment of Mr. George Skinner as Director of Commercial Operations for its revolutionary FASTinov® technology. With an extensive background in the diagnostics industry and a proven track record in launching leading products across various regions worldwide, Mr. Skinner brings invaluable expertise and leadership to FASTinov’s commercial endeavours.

Mr. Skinner’s appointment comes at a pivotal time for FASTinov as it continues to expand its presence in Europe and prepare for further global expansion. With his wealth of experience gained from working with both startups and multinational corporations in the diagnostics sector, Mr. Skinner is poised to drive growth and strengthen FASTinov’s ability to serve customers effectively.

Nuno Afonso, CEO of FASTinov, expressed his excitement about Mr. Skinner joining the team.
“We are thrilled to welcome George Skinner to FASTinov as our Director of Commercial Operations. His extensive experience and proven track record in the diagnostics industry make him the ideal candidate to lead our commercial efforts as we continue to grow and expand our presence in Europe and beyond.”

Mr. Skinner’s expertise in launching and commercializing innovative diagnostics products will be instrumental in accelerating the adoption of FASTinov® technology and delivering value to customers. His strategic insights and leadership will further enhance FASTinov’s ability to meet the evolving needs of healthcare providers and patients worldwide.

“We are confident that George’s leadership will bring new strength to our commercial operations and drive success for FASTinov in the dynamic diagnostics market,”
added Dr. Cidália Pina Vaz, Chief Scientific Officer of FASTinov.
“His passion for innovation and commitment to customer satisfaction align perfectly with our mission to revolutionize patient care through cutting-edge technology.”

Mr. Skinner expressed his enthusiasm for joining FASTinov and contributing to its growth trajectory. “I am excited to join FASTinov and lead its commercial operations during this exciting phase of growth and expansion. I look forward to leveraging my experience and working closely with the team to bring FASTinov® technology to healthcare providers across Europe and beyond.”

With Mr. Skinner’s appointment, FASTinov reaffirms its commitment to driving innovation and excellence in rapid antimicrobial susceptibility testing, positioning itself as a global leader in the fight against infectious diseases.

About FASTinov

FASTinov is a leading innovator in rapid antimicrobial susceptibility testing, dedicated to revolutionizing patient care in sepsis contexts. With a mission to provide actionable same-shift results, FASTinov’s cutting-edge technology offers healthcare professionals unprecedented insights for targeted treatment decisions.

Share with friends